Author: news_poster
Posted: Thu Sep 15, 2011 2:00 am
Source: Canadian Agency for Drugs and Technologies in Health (CADTH)
Area: News
This Rapid Response Report from the Canadian Agency for Drugs and Technologies in Health (CADTH) discusses the available evidence regarding the comparative clinical efficacy and safety of short term (<4 weeks) use of Suboxone® (buprenorphine/naloxone) compared with other opioid detoxification agents such as buprenorphine alone, methadone, and clonidine, and placebo.
The results of their limited literature search are described and summarised in the report (see link below); the main conclusions drawn were as follows:
. The evidence comparing the clinical effectiveness of short term Suboxone® detoxification with other alternative medications in the treatment of patients with opioid…
Source: MedWorm Query: Buprenorphine
MedWorm.com provides a medical RSS filtering service. Data from over 6000 medical RSS feeds is collected and output via different categories. This feed contains the latest headlines from the user generated query: Buprenorphine
